|
MDA-19 is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB2, with reasonable selectivity over the psychoactive CB1 receptor, though with some variation between species. In animal studies it was effective for the treatment of neuropathic pain, but failed to produce cannabis-like behavioural effects.〔Xu JJ, ''et al.'' Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain. ''Anesthesia and Analgesia''. 2010 Jul;111(1):99-109. PMID 20522703〕 ==See also== * AM-1221 * JTE 7-31 * JWH-019 * JWH-133 * N-(S)-Fenchyl-1-(2-morpholinoethyl)-7-methoxyindole-3-carboxamide 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「MDA-19」の詳細全文を読む スポンサード リンク
|